Published in Am J Otol on January 01, 2000
Role of electrode placement as a contributor to variability in cochlear implant outcomes. Otol Neurotol (2008) 2.71
Frequency map for the human cochlear spiral ganglion: implications for cochlear implants. J Assoc Res Otolaryngol (2007) 2.15
Acoustic to electric pitch comparisons in cochlear implant subjects with residual hearing. J Assoc Res Otolaryngol (2006) 1.46
Implications of deep electrode insertion on cochlear implant fitting. J Assoc Res Otolaryngol (2007) 1.30
Psychophysical versus physiological spatial forward masking and the relation to speech perception in cochlear implants. Ear Hear (2008) 1.20
Consensus panel on a cochlear coordinate system applicable in histologic, physiologic, and radiologic studies of the human cochlea. Otol Neurotol (2010) 1.16
Electrode interaction in pediatric cochlear implant subjects. J Assoc Res Otolaryngol (2005) 1.12
The Relationship Between Insertion Angles, Default Frequency Allocations, and Spiral Ganglion Place Pitch in Cochlear Implants. Ear Hear (2015) 1.02
Verification of computed tomographic estimates of cochlear implant array position: a micro-CT and histologic analysis. Otol Neurotol (2011) 0.93
Abnormal pitch perception produced by cochlear implant stimulation. PLoS One (2014) 0.92
An improved cochlear implant electrode array for use in experimental studies. Hear Res (2011) 0.91
Partial withdrawal of deeply inserted cochlear electrodes: observations of two patients. Eur Arch Otorhinolaryngol (2007) 0.90
Intracochlear assessment of electrode position after cochlear implant surgery by means of multislice computer tomography. Eur Arch Otorhinolaryngol (2007) 0.89
Comparison of Interaural Electrode Pairing Methods for Bilateral Cochlear Implants. Trends Hear (2015) 0.88
Frequency-place map for electrical stimulation in cochlear implants: Change over time. Hear Res (2015) 0.87
Cochlea size variability and implications in clinical practice. Acta Otorhinolaryngol Ital (2014) 0.87
Effects of stimulation level and electrode pairing on the binaural interaction component of the electrically evoked auditory brain stem response. Ear Hear (2010) 0.84
Measurement of Cochlear Implant Electrode Position From Intraoperative Post-insertion Skull Radiographs: A Validation Study. Otol Neurotol (2015) 0.82
Insertion characteristics and placement of the Mid-Scala electrode array in human temporal bones using detailed cone beam computed tomography. Eur Arch Otorhinolaryngol (2016) 0.78
Estimation of insertion depth angle based on cochlea diameter and linear insertion depth: a prediction tool for the CI422. Eur Arch Otorhinolaryngol (2014) 0.77
Imaging of electrode position in relation to electrode functioning after cochlear implantation. Eur Arch Otorhinolaryngol (2009) 0.77
Cochlear Dummy Electrodes for Insertion Training and Research Purposes: Fabrication, Mechanical Characterization, and Experimental Validation. Biomed Res Int (2015) 0.75
Pitch Matching between Electrical Stimulation of a Cochlear Implant and Acoustic Stimuli Presented to a Contralateral Ear with Residual Hearing. J Am Acad Audiol (2017) 0.75
Imaging in cochlear implant patients. GMS Curr Top Otorhinolaryngol Head Neck Surg (2012) 0.75
Evaluation of the Relationship between the NRT-Ratio, Cochlear Anatomy, and Insertions Depth of Perimodiolar Cochlear Implant Electrodes. Biomed Res Int (2015) 0.75
Scanning electrochemical microscopy as a novel proximity sensor for atraumatic cochlear implant insertion. IEEE Trans Biomed Eng (2014) 0.75
Imaging of Electrode Position after Cochlear Implantation with Flat Panel CT. ISRN Otolaryngol (2012) 0.75
Initial Operative Experience and Short-term Hearing Preservation Results With a Mid-scala Cochlear Implant Electrode Array. Otol Neurotol (2016) 0.75
Controlling the position and the dislocation of the middle ear transducer with high-resolution computed tomography and digital volume tomography: implications for the transducers' design. Eur Arch Otorhinolaryngol (2011) 0.75
Spiral Form of the Human Cochlea Results from Spatial Constraints. Sci Rep (2017) 0.75
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 49.88
Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol (1998) 11.84
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol (1999) 11.18
REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer (2005) 4.85
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst (1993) 4.45
Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst (1994) 4.28
Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst (2000) 4.26
Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med (1992) 3.55
Cathepsin D and prognosis in breast cancer. N Engl J Med (1990) 3.43
HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol (1989) 2.96
Speech perception as a function of electrical stimulation rate: using the Nucleus 24 cochlear implant system. Ear Hear (2000) 2.51
Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol (1993) 2.42
Evaluation of a new spectral peak coding strategy for the Nucleus 22 Channel Cochlear Implant System. Am J Otol (1994) 2.37
Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol (1999) 2.32
HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res (1990) 2.14
Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res (1985) 2.13
Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol (1987) 2.12
Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst (1998) 2.06
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol (1992) 2.05
Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers. J Natl Cancer Inst (1992) 2.05
Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst (1993) 1.95
How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst (1990) 1.95
Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol (1999) 1.89
Time-dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res Treat (1998) 1.85
Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol (1984) 1.84
Breast cancer outcome and predictors of outcome: are there age differentials? J Natl Cancer Inst Monogr (1994) 1.79
Progesterone receptors as a prognostic factor in Stage II breast cancer. N Engl J Med (1983) 1.79
Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst (1994) 1.77
Epidemiology of an international outbreak of Salmonella agona. Lancet (1973) 1.76
DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer (1988) 1.75
Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. BMJ (1995) 1.75
Loss of heterozygosity at D14S62 and metastatic potential of breast cancer. J Natl Cancer Inst (1999) 1.75
Why do so many prognostic factors fail to pan out? Breast Cancer Res Treat (1992) 1.74
Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer (1998) 1.72
Intracochlear factors contributing to psychophysical percepts following cochlear implantation. Acta Otolaryngol (1998) 1.68
Electrical stimulation of the auditory nerve: the effect of electrode position on neural excitation. Hear Res (1993) 1.66
Variation in speech perception scores among children with cochlear implants. Ear Hear (2001) 1.64
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen. J Clin Oncol (2005) 1.63
Evaluation of methods for isolating Salmonella and Arizona organisms from pet turtles. Appl Microbiol (1974) 1.62
Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear (1999) 1.60
Changing distribution of primary cancers in the large bowel. JAMA (1977) 1.59
Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol (1999) 1.55
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. J Clin Oncol (1992) 1.55
Speech perception using a two-formant 22-electrode cochlear prosthesis in quiet and in noise. Acta Otolaryngol (1988) 1.53
Multiple estrogen receptor assays in human breast cancer. Cancer Res (1983) 1.52
Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res (1993) 1.51
The relationship between speech perception and electrode discrimination in cochlear implantees. J Acoust Soc Am (2000) 1.49
Psychophysical studies with two binaural cochlear implant subjects. J Acoust Soc Am (1997) 1.49
Childhood cancer: nonmedical costs of the illness. Cancer (1979) 1.48
Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. Br J Cancer (1987) 1.44
Prospective clinical trial of a human tumor cloning system. Cancer Res (1983) 1.44
Amplification of c-erbB-2 and aggressive human breast tumors? Science (1988) 1.43
Profound hearing loss in the cat following the single co-administration of kanamycin and ethacrynic acid. Hear Res (1993) 1.41
Pitch comparisons of acoustically and electrically evoked auditory sensations. Hear Res (1996) 1.40
Computer-aided three-dimensional reconstruction in human cochlear maps: measurement of the lengths of organ of Corti, outer wall, inner wall, and Rosenthal's canal. Ann Otol Rhinol Laryngol (1996) 1.40
Chronic electrical stimulation of the auditory nerve at high stimulus rates: a physiological and histopathological study. Hear Res (1997) 1.39
A method for the evaluation of dose-toxicity relationships in clinical trials. Stat Med (1989) 1.39
Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res (1983) 1.37
Short-term auditory memory in children using cochlear implants and its relevance to receptive language. J Speech Lang Hear Res (2002) 1.36
Combined electrical and acoustical stimulation using a bimodal prosthesis. Arch Otolaryngol Head Neck Surg (1993) 1.36
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. Breast Cancer Res Treat (1993) 1.36
Current attitudes of medical personnel toward computers. Comput Biomed Res (1979) 1.35
Factors predicting postoperative sentence scores in postlinguistically deaf adult cochlear implant patients. Ann Otol Rhinol Laryngol (1992) 1.35
Pitch percepts associated with amplitude-modulated current pulse trains in cochlear implantees. J Acoust Soc Am (1994) 1.27
Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer. Clin Cancer Res (1996) 1.26
Absolute identification of electric pulse rates and electrode positions by cochlear implant patients. J Acoust Soc Am (1985) 1.25
DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat (1993) 1.25
bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study. J Clin Oncol (1997) 1.23
Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J Natl Cancer Inst (1990) 1.22
Multiple progesterone receptor assays in human breast cancer. Cancer Res (1984) 1.21
bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer (1998) 1.21
Localization of the calmodulin- and the actin-binding sites of caldesmon. J Biol Chem (1991) 1.21
Prognostic significance of p53 gene alterations in node-negative breast cancer. Breast Cancer Res Treat (1993) 1.20
Psychophysical studies for two multiple-channel cochlear implant patients. J Acoust Soc Am (1982) 1.20
HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study. Clin Cancer Res (1998) 1.20
Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br J Cancer (1991) 1.20
Pitch perception for different modes of stimulation using the cochlear multiple-electrode prosthesis. J Acoust Soc Am (1994) 1.19
Evaluation of a portable two-microphone adaptive beamforming speech processor with cochlear implant patients. J Acoust Soc Am (1995) 1.19
p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer. Cancer Res (1994) 1.18
A comparison of questionnaire versus monofilament assessment of neurosensory deficit. J Oral Maxillofac Surg (1996) 1.17
Changes in synthetic and natural vowel perception after specific training for congenitally deafened patients using a multichannel cochlear implant. Ear Hear (1997) 1.15
A practical application of neural network analysis for predicting outcome of individual breast cancer patients. Breast Cancer Res Treat (1992) 1.15
Insulin-like growth factor-binding protein-3 and breast cancer survival. Int J Cancer (1998) 1.14
Comparison of electrode position in the human cochlea using various perimodiolar electrode arrays. Am J Otol (2000) 1.14
Binding of oestradiol to blood proteins and aetiology of breast cancer. Int J Cancer (1986) 1.14
Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference. Cytometry (1993) 1.13
Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential. Clin Cancer Res (2000) 1.13
Radiologic evaluation of multichannel intracochlear implant insertion depth. Am J Otol (1993) 1.12
Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain. J Endocrinol (1988) 1.12
Results of speech perception and speech production training for three prelingually deaf patients using a multiple-electrode cochlear implant. Br J Audiol (1991) 1.12
Reporting recommendations for tumor marker prognostic studies (remark). Exp Oncol (2006) 1.12
Cochlear pathology following chronic electrical stimulation of the auditory nerve. I: Normal hearing kittens. Hear Res (1992) 1.12
Surgical complications with the cochlear multiple-channel intracochlear implant: experience at Hannover and Melbourne. Ann Otol Rhinol Laryngol (1991) 1.11
Forward masking patterns produced by intracochlear electrical stimulation of one and two electrode pairs in the human cochlea. J Acoust Soc Am (1989) 1.11
Psychophysical studies evaluating the feasibility of a speech processing strategy for a multiple-channel cochlear implant. J Acoust Soc Am (1983) 1.11